Close

Aquestive Therapeutics Receives Notification from FDA that It Will Not Be Ready to Take Action by December 23, 2021 for the Company’s NDA for Libervant™ (diazepam) Buccal Film

Go back to Aquestive Therapeutics Receives Notification from FDA that It Will Not Be Ready to Take Action by December 23, 2021 for the Company’s NDA for Libervant™ (diazepam) Buccal Film
(NASDAQ: AQST) Delayed: 4.28 -0.1 (2.28%)
Previous Close $4.38    52 Week High
Open $4.38    52 Week Low
Day High $4.50    P/E N/A 
Day Low $4.24    EPS
Volume 1,693,047